Report Detail

Pharma & Healthcare Global Pirfenidone Market Status and Forecast 2021-2027

  • RnM4336324
  • |
  • 23 July, 2021
  • |
  • Global
  • |
  • 163 Pages
  • |
  • GRD Survey
  • |
  • Pharma & Healthcare

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Pirfenidone Market Status and Forecast (2016-2027)
      • 1.3.2 Global Pirfenidone Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Pirfenidone Supply by Company

    • 2.1 Global Pirfenidone Sales Volume by Company
    • 2.2 Global Pirfenidone Sales Value by Company
    • 2.3 Global Pirfenidone Price by Company
    • 2.4 Pirfenidone Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional Pirfenidone Market Status by Type

    • 3.1 Pirfenidone Type Introduction
      • 3.1.1 Tablet
      • 3.1.2 Capsule
      • 3.1.3 Other
    • 3.2 Global Pirfenidone Market by Type
      • 3.2.1 Global Pirfenidone Sales Volume by Type (2016-2021)
      • 3.2.2 Global Pirfenidone Sales Value by Type (2016-2021)
      • 3.2.3 Global Pirfenidone Price by Type (2016-2021)
    • 3.3 North America: by Type
    • 3.4 Europe: by Type
    • 3.5 Asia Pacific: by Type
    • 3.6 Central & South America: by Type
    • 3.7 Middle East & Africa: by Type

    4 Global and Regional Pirfenidone Market Status by Application

    • 4.1 Pirfenidone Segment by Application
      • 4.1.1 Mild Idiopathic Pulmonary Fibrosis
      • 4.1.2 Moderate Idiopathic Pulmonary Fibrosis
      • 4.1.3 Other
    • 4.2 Global Pirfenidone Market by Application
      • 4.2.1 Global Pirfenidone Sales Volume by Application (2016-2021)
      • 4.2.2 Global Pirfenidone Sales Value by Application (2016-2021)
      • 4.2.3 Global Pirfenidone Price by Application (2016-2021)
    • 4.3 North America: by Application
    • 4.4 Europe: by Application
    • 4.5 Asia Pacific: by Application
    • 4.6 Central & South America: by Application
    • 4.7 Middle East & Africa: by Application

    5 Global Pirfenidone Market Status by Region

    • 5.1 Global Pirfenidone Market by Region
      • 5.1.1 Global Pirfenidone Sales Volume by Region
      • 5.1.2 Global Pirfenidone Sales Value by Region
    • 5.2 North America Pirfenidone Market Status
    • 5.3 Europe Pirfenidone Market Status
    • 5.4 Asia Pacific Pirfenidone Market Status
    • 5.5 Central & South America Pirfenidone Market Status
    • 5.6 Middle East & Africa Pirfenidone Market Status

    6 North America Pirfenidone Market Status

    • 6.1 North America Pirfenidone Market by Country
      • 6.1.1 North America Pirfenidone Sales Volume by Country (2016-2021)
      • 6.1.2 North America Pirfenidone Sales Value by Country (2016-2021)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Pirfenidone Market Status

    • 7.1 Europe Pirfenidone Market by Country
      • 7.1.1 Europe Pirfenidone Sales Volume by Country (2016-2021)
      • 7.1.2 Europe Pirfenidone Sales Value by Country (2016-2021)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Pirfenidone Market Status

    • 8.1 Asia Pacific Pirfenidone Market by Country
      • 8.1.1 Asia Pacific Pirfenidone Sales Volume by Country (2016-2021)
      • 8.1.2 Asia Pacific Pirfenidone Sales Value by Country (2016-2021)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Pirfenidone Market Status

    • 9.1 Central & South America Pirfenidone Market by Country
      • 9.1.1 Central & South America Pirfenidone Sales Volume by Country (2016-2021)
      • 9.1.2 Central & South America Pirfenidone Sales Value by Country (2016-2021)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Pirfenidone Market Status

    • 10.1 Middle East & Africa Pirfenidone Market by Country
      • 10.1.1 Middle East & Africa Pirfenidone Sales Volume by Country (2016-2021)
      • 10.1.2 Middle East & Africa Pirfenidone Sales Value by Country (2016-2021)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Supply Chain and Manufacturing Cost Analysis

    • 11.1 Supply Chain Analysis
    • 11.2 Production Process Chart Analysis
    • 11.3 Raw Materials and Key Suppliers Analysis
      • 11.3.1 Raw Materials Introduction
      • 11.3.2 Raw Materials Key Suppliers List
    • 11.4 Pirfenidone Manufacturing Cost Analysis
    • 11.5 Pirfenidone Sales Channel and Distributors Analysis
      • 11.5.1 Pirfenidone Sales Channel
      • 11.5.2 Pirfenidone Distributors
    • 11.6 Pirfenidone Downstream Major Buyers

    12 Global Pirfenidone Market Forecast by Type and by Application

    • 12.1 Global Pirfenidone Sales Volume and Sales Value Forecast (2022-2027)
    • 12.2 Global Pirfenidone Forecast by Type
      • 12.2.1 Global Pirfenidone Sales Volume Forecast by Type
      • 12.2.2 Global Pirfenidone Sales Value Forecast by Type
      • 12.2.3 Global Pirfenidone Price Forecast by Type
    • 12.3 Global Pirfenidone Forecast by Application
      • 12.3.1 Global Pirfenidone Sales Volume Forecast by Application
      • 12.3.2 Global Pirfenidone Sales Value Forecast by Application
      • 12.3.3 Global Pirfenidone Price Forecast by Application

    13 Global Pirfenidone Market Forecast by Region/Country

    • 13.1 Global Pirfenidone Market Forecast by Region (2022-2027)
      • 13.1.1 Global Pirfenidone Sales Volume Forecast by Region (2022-2027)
      • 13.1.2 Global Pirfenidone Sales Value Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Zydus Cadila
      • 14.1.1 Company Information
      • 14.1.2 Pirfenidone Product Introduction
      • 14.1.3 Zydus Cadila Pirfenidone Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.1.4 SWOT Analysis
    • 14.2 Wockhardt
      • 14.2.1 Company Information
      • 14.2.2 Pirfenidone Product Introduction
      • 14.2.3 Wockhardt Pirfenidone Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.2.4 SWOT Analysis
    • 14.3 Unimed Unihealth
      • 14.3.1 Company Information
      • 14.3.2 Pirfenidone Product Introduction
      • 14.3.3 Unimed Unihealth Pirfenidone Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.3.4 SWOT Analysis
    • 14.4 Shionogi
      • 14.4.1 Company Information
      • 14.4.2 Pirfenidone Product Introduction
      • 14.4.3 Shionogi Pirfenidone Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.4.4 SWOT Analysis
    • 14.5 MSN Laboratories
      • 14.5.1 Company Information
      • 14.5.2 Pirfenidone Product Introduction
      • 14.5.3 MSN Laboratories Pirfenidone Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.5.4 SWOT Analysis
    • 14.6 Lupin Ltd
      • 14.6.1 Company Information
      • 14.6.2 Pirfenidone Product Introduction
      • 14.6.3 Lupin Ltd Pirfenidone Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.6.4 SWOT Analysis
    • 14.7 Koye Pharmaceuticals
      • 14.7.1 Company Information
      • 14.7.2 Pirfenidone Product Introduction
      • 14.7.3 Koye Pharmaceuticals Pirfenidone Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.7.4 SWOT Analysis
    • 14.8 Incepta Pharmaceuticals
      • 14.8.1 Company Information
      • 14.8.2 Pirfenidone Product Introduction
      • 14.8.3 Incepta Pharmaceuticals Pirfenidone Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.8.4 SWOT Analysis
    • 14.9 GNI Group
      • 14.9.1 Company Information
      • 14.9.2 Pirfenidone Product Introduction
      • 14.9.3 GNI Group Pirfenidone Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.9.4 SWOT Analysis
    • 14.10 Glenmark Pharmaceuticals
      • 14.10.1 Company Information
      • 14.10.2 Pirfenidone Product Introduction
      • 14.10.3 Glenmark Pharmaceuticals Pirfenidone Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.10.4 SWOT Analysis
    • 14.11 Genentech (Roche)
    • 14.12 Cipla
    • 14.13 Beijing Continent

    15 Conclusion

      16 Methodology

      This report provides a comprehensive analysis of current global Pirfenidone market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario. This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Pirfenidone industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

      According to this survey, the global Pirfenidone market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million by 2027.

      Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Pirfenidone Market Status and Forecast 2021-2027 report makes a brilliant attempt to unveil key opportunities available in the global Pirfenidone market under the covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

      The Global Pirfenidone Market has been exhibited in detail in the following chapters
      Chapter 1 displays the basic product introduction and market overview.
      Chapter 2 provides the competition landscape of global Pirfenidone industry.
      Chapter 3 provides the market analysis by type and by region
      Chapter 4 provides the market analysis by application and by region
      Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
      Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
      Chapter 12 provides the market forecast by type and by application
      Chapter 13 provides the market forecast by region
      Chapter 14 profiles global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
      Chapter 15 conclusions

      Segmented by Type
      Tablet
      Capsule

      Segmented by Application
      Mild Idiopathic Pulmonary Fibrosis
      Moderate Idiopathic Pulmonary Fibrosis
      Other

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      Unimed Unihealth
      Shionogi
      MSN Laboratories
      Lupin Ltd
      Koye Pharmaceuticals
      Incepta Pharmaceuticals
      GNI Group
      Glenmark Pharmaceuticals
      Genentech (Roche)
      Cipla
      Beijing Continent


      Summary:
      Get latest Market Research Reports on Pirfenidone. Industry analysis & Market Report on Pirfenidone is a syndicated market report, published as Global Pirfenidone Market Status and Forecast 2021-2027. It is complete Research Study and Industry Analysis of Pirfenidone market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $2,980.00
      $4,470.00
      $5,960.00
      2,172.42
      3,258.63
      4,344.84
      2,538.96
      3,808.44
      5,077.92
      330,482.00
      495,723.00
      660,964.00
      219,924.00
      329,886.00
      439,848.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report